United States

Stine Jacobsen

Jeff Mason is a White House Correspondent for Reuters and the 2016-2017 president of the White House Correspondents’ Association. He was the lead Reuters correspondent for President Barack Obama's 2012 campaign and interviewed the president at the White House in 2015. Jeff has been based in Washington since 2008, when he covered the historic race between Obama, Hillary Clinton and John McCain. Jeff started his career in Frankfurt, Germany, where he covered the airline industry before moving to Brussels, Belgium, where he covered the European Union. He is a Colorado native, proud graduate of Northwestern University and former Fulbright scholar.

Twitter handle: @jeffmason1

May 16 2018

Sivantos and Widex in $8 billion merger to create No.3 in hearing aids

COPENHAGEN/FRANKFURT Hearing aid makers Widex and Sivantos are merging to create an industry number three that can invest more in digital devices and step up the challenge to market leaders Sonova and William Demant.

May 04 2018

Global wind turbine makers hit by subsidy squeeze

COPENHAGEN/MADRID Shares in rival wind turbine makers Siemens Gamesa and Vestas fell on Friday as a squeeze on prices caused by reduced state subsidies took its toll on quarterly profits.

May 02 2018

Novo Nordisk upbeat on new diabetes drug as profit tops forecast

COPENHAGEN Novo Nordisk , the world's biggest maker of diabetes drugs, reported a smaller than expected fall in first-quarter profit and nudged up its full-year forecast as sales of new medicines helped to soften the hit from a weaker U.S. dollar.

Apr 30 2018

Offshore wind power firms see Taiwan as a battleground to expand in Asia

COPENHAGEN Taiwan is becoming the next battleground for the world's top offshore wind developers as they seek a foothold in Asia for a technology that has been expanding fast in Europe.

Apr 10 2018

Biotech group Genmab aims to own bigger share of new drug pipeline

COPENHAGEN, April 10 Genmab plans to own a bigger share of drugs in its early-stage pipeline as Europe's biggest biotechnology company prepares to reduce its reliance on a blockbuster cancer drug, marketed by partner Johnson & Johnson.

Apr 04 2018

Vestas taps car battery know-how for wind power storage

COPENHAGEN The world's largest wind turbine maker Vestas is tapping into experience from the car battery industry to try to address the challenge of using erratic wind and solar energy to meet a growing share of power demand.

Mar 26 2018

Denmark faces dilemma over Russian gas pipeline

BRUSSELS/COPENHAGEN Denmark is under pressure to rule on whether a new Russian pipeline supplying gas to Germany can be built near its Baltic coast, a decision that puts it in the line of fire from friend and foe alike.  

Mar 22 2018

Drugmaker Novo Nordisk looks to former oil boss to energize M&A

COPENHAGEN Leading diabetes drugmaker Novo Nordisk has named former oil boss Helge Lund as its new chairman as the company contends with increasing price pressure and seeks acquisitions to broaden its blood products line-up.

Mar 13 2018

Maersk's port business woos customers with new transport services

COPENHAGEN Danish shipping group A.P. Moller-Maersk's is betting on winning new customers for its port division by becoming a one-stop shop that can transport goods from factory to retailers' shelves.

Feb 22 2018

Novo's pioneering diabetes pill impresses in first big study

COPENHAGEN/LONDON The world's largest diabetes drugmaker, Novo Nordisk, on Thursday presented the first successful data from a large final-stage study of a pill it hopes will transform the diabetes market.


  • U.S.
  • Europe
  • Asia
  • Sectors

Sector Summary